Published in Proc Natl Acad Sci U S A on October 30, 2006
Understanding protein non-folding. Biochim Biophys Acta (2010) 4.33
The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics (2008) 2.72
A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc Natl Acad Sci U S A (2007) 2.62
Classification of intrinsically disordered regions and proteins. Chem Rev (2014) 2.48
From the Cover: Charge interactions can dominate the dimensions of intrinsically disordered proteins. Proc Natl Acad Sci U S A (2010) 2.37
Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci U S A (2010) 2.16
Biophysical characterization of intrinsically disordered proteins. Curr Opin Struct Biol (2009) 1.98
Fluorescence correlation spectroscopy: past, present, future. Biophys J (2011) 1.65
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60
ABSINTH: a new continuum solvation model for simulations of polypeptides in aqueous solutions. J Comput Chem (2009) 1.57
Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. Biophys J (2007) 1.53
Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol (2008) 1.43
The folding of single domain proteins--have we reached a consensus? Curr Opin Struct Biol (2010) 1.42
Unfoldomics of human diseases: linking protein intrinsic disorder with diseases. BMC Genomics (2009) 1.41
A polymer physics perspective on driving forces and mechanisms for protein aggregation. Arch Biochem Biophys (2007) 1.41
Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2013) 1.39
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment. J Biol Chem (2009) 1.37
Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J Mol Biol (2012) 1.37
Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. J Mol Biol (2009) 1.36
Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nat Struct Mol Biol (2009) 1.35
Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem (2010) 1.35
Polymer scaling laws of unfolded and intrinsically disordered proteins quantified with single-molecule spectroscopy. Proc Natl Acad Sci U S A (2012) 1.34
Protein aggregation processes: In search of the mechanism. Protein Sci (2007) 1.32
Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol (2009) 1.30
Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem (2010) 1.28
Single homopolypeptide chains collapse into mechanically rigid conformations. Proc Natl Acad Sci U S A (2009) 1.25
The predicted structure of the headpiece of the Huntingtin protein and its implications on Huntingtin aggregation. J Mol Biol (2009) 1.24
In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence. J Biol Chem (2007) 1.19
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides. Biophys Chem (2011) 1.13
Protein disorder in the human diseasome: unfoldomics of human genetic diseases. BMC Genomics (2009) 1.11
Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci U S A (2010) 1.11
Thermodynamics of beta-sheet formation in polyglutamine. Biophys J (2009) 1.07
Relating sequence encoded information to form and function of intrinsically disordered proteins. Curr Opin Struct Biol (2015) 1.06
Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol (2017) 1.01
Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR. J Mol Biol (2008) 1.01
Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem Biol (2010) 1.00
Describing sequence-ensemble relationships for intrinsically disordered proteins. Biochem J (2013) 1.00
Assessing the solvent-dependent surface area of unfolded proteins using an ensemble model. Proc Natl Acad Sci U S A (2008) 1.00
Small-angle X-ray scattering and single-molecule FRET spectroscopy produce highly divergent views of the low-denaturant unfolded state. J Mol Biol (2012) 0.97
Phase separation in biology; functional organization of a higher order. Cell Commun Signal (2016) 0.97
The impact of ataxin-1-like histidine insertions on polyglutamine aggregation. Protein Eng Des Sel (2009) 0.97
β-hairpin-mediated nucleation of polyglutamine amyloid formation. J Mol Biol (2013) 0.96
Temperature-dependent solvation modulates the dimensions of disordered proteins. Proc Natl Acad Sci U S A (2014) 0.96
N-terminal domains of DELLA proteins are intrinsically unstructured in the absence of interaction with GID1/gibberellic acid receptors. J Biol Chem (2010) 0.95
Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect. Biophys J (2009) 0.95
Thermodynamics, kinetics, and salt dependence of folding of YopM, a large leucine-rich repeat protein. J Mol Biol (2008) 0.95
Insights into structure, stability, and toxicity of monomeric and aggregated polyglutamine models from molecular dynamics simulations. Biophys J (2008) 0.94
UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization. Biochemistry (2012) 0.91
Fluorescence characterization of denatured proteins. Curr Opin Struct Biol (2008) 0.90
Kinetics of contact formation and end-to-end distance distributions of swollen disordered peptides. Biophys J (2009) 0.90
Shedding light on protein folding landscapes by single-molecule fluorescence. Chem Soc Rev (2014) 0.89
Denaturant-induced expansion and compaction of a multi-domain protein: IgG. J Mol Biol (2008) 0.89
Trinucleotide repeats: a structural perspective. Front Neurol (2013) 0.89
Hydrogen-bond driven loop-closure kinetics in unfolded polypeptide chains. PLoS Comput Biol (2010) 0.89
A quantitative measure for protein conformational heterogeneity. J Chem Phys (2013) 0.88
Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry (2014) 0.87
Chain collapse of an amyloidogenic intrinsically disordered protein. Biophys J (2011) 0.87
Cell-to-cell variability in the propensity to transcribe explains correlated fluctuations in gene expression. Cell Syst (2015) 0.85
Hamiltonian Switch Metropolis Monte Carlo Simulations for Improved Conformational Sampling of Intrinsically Disordered Regions Tethered to Ordered Domains of Proteins. J Chem Theory Comput (2014) 0.85
A coarse-grained model for polyglutamine aggregation modulated by amphipathic flanking sequences. Biophys J (2014) 0.84
Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion. Brain Sci (2014) 0.84
Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein. PLoS One (2012) 0.84
Aggregation kinetics of interrupted polyglutamine peptides. J Mol Biol (2011) 0.84
Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo. J Biol Chem (2012) 0.84
Quantitative assessments of the distinct contributions of polypeptide backbone amides versus side chain groups to chain expansion via chemical denaturation. J Am Chem Soc (2015) 0.83
Understanding protein aggregation from the view of monomer dynamics. Mol Biosyst (2012) 0.83
Dynamic Protein Interaction Networks and New Structural Paradigms in Signaling. Chem Rev (2016) 0.82
Probing protein disorder and complexity at single-molecule resolution. Semin Cell Dev Biol (2014) 0.82
Amyloids go genomic: insights regarding the sequence determinants of prion formation from genome-wide studies. Chembiochem (2009) 0.82
A platform to view huntingtin exon 1 aggregation flux in the cell reveals divergent influences from chaperones hsp40 and hsp70. J Biol Chem (2013) 0.82
Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer. PLoS One (2016) 0.80
Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs). Int J Mol Sci (2011) 0.80
CAMELOT: A machine learning approach for coarse-grained simulations of aggregation of block-copolymeric protein sequences. J Chem Phys (2015) 0.78
An Analysis of Biomolecular Force Fields for Simulations of Polyglutamine in Solution. Biophys J (2015) 0.78
An intrinsically disordered linker plays a critical role in bacterial cell division. Semin Cell Dev Biol (2014) 0.78
Importance of Hydrophilic Hydration and Intramolecular Interactions in the Thermodynamics of Helix-Coil Transition and Helix-Helix Assembly in a Deca-Alanine Peptide. J Phys Chem B (2015) 0.78
Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations. J Mol Model (2013) 0.77
Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection. Protein Sci (2015) 0.77
Stable polyglutamine dimers can contain β-hairpins with interdigitated side chains-but not α-helices, β-nanotubes, β-pseudohelices, or steric zippers. Biophys J (2014) 0.77
Dynamics and dimension of an amyloidogenic disordered state of human β(2)-microglobulin. Eur Biophys J (2013) 0.76
Solvation Thermodynamics of Oligoglycine with Respect to Chain Length and Flexibility. Biophys J (2016) 0.76
Huntingtin fragments and SOD1 mutants form soluble oligomers in the cell. PLoS One (2012) 0.76
Backbone engineering within a latent β-hairpin structure to design inhibitors of polyglutamine amyloid formation. J Mol Biol (2016) 0.75
Dimensions, energetics, and denaturant effects of the protein unstructured state. Protein Sci (2016) 0.75
Conformational properties of polyglutamine sequences in guanidine hydrochloride solutions. Biophys J (2012) 0.75
Actinous enigma or enigmatic actin: Folding, structure, and functions of the most abundant eukaryotic protein. Intrinsically Disord Proteins (2014) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Fluorescence correlation spectroscopy. II. An experimental realization. Biopolymers (1974) 17.35
Dominant forces in protein folding. Biochemistry (1990) 15.34
Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol (1984) 13.69
Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A (1994) 6.96
Natively unfolded proteins: a point where biology waits for physics. Protein Sci (2002) 6.91
Hydrophobicity of amino acid residues in globular proteins. Science (1985) 5.64
How do small single-domain proteins fold? Fold Des (1998) 5.23
Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A (2002) 4.66
Random-coil behavior and the dimensions of chemically unfolded proteins. Proc Natl Acad Sci U S A (2004) 4.44
Analysis of protein aggregation kinetics. Methods Enzymol (1999) 3.97
Amyloid fibrils from muscle myoglobin. Nature (2001) 3.93
Surface and inside volumes in globular proteins. Nature (1979) 3.91
Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta (2004) 3.69
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol (2004) 3.51
Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol (2005) 3.18
Fourteen and counting: unraveling trinucleotide repeat diseases. Hum Mol Genet (2000) 3.06
Polymer principles and protein folding. Protein Sci (1999) 3.04
Polymer principles in protein structure and stability. Annu Rev Biophys Biophys Chem (1991) 2.81
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol (2001) 2.80
Is there a unifying mechanism for protein folding? Trends Biochem Sci (2003) 2.63
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry (2002) 2.59
Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol (2004) 2.50
Coil-globule transition in the denatured state of a small protein. Proc Natl Acad Sci U S A (2006) 2.27
Pathways for protein folding: is a new view needed? Curr Opin Struct Biol (1998) 2.26
End-to-end distance distributions and intrachain diffusion constants in unfolded polypeptide chains indicate intramolecular hydrogen bond formation. Proc Natl Acad Sci U S A (2006) 2.23
Identification and functions of usefully disordered proteins. Adv Protein Chem (2002) 2.23
Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J Mol Biol (2005) 2.10
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Solubilization and disaggregation of polyglutamine peptides. Protein Sci (2001) 2.00
Polymerization of actin and actin-like systems: evaluation of the time course of polymerization in relation to the mechanism. Biochemistry (1983) 1.82
The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration". Biophys J (2006) 1.82
Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins. FEBS Lett (2002) 1.78
Huntington's disease: seeing the pathogenic process through a genetic lens. Trends Biochem Sci (2006) 1.72
Aspects on human amyloid forms and their fibril polypeptides. FEBS J (2005) 1.71
A linear lattice model for polyglutamine in CAG-expansion diseases. Proc Natl Acad Sci U S A (2002) 1.62
Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta (2005) 1.58
polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci U S A (2005) 1.57
Characterizing the conformational ensemble of monomeric polyglutamine. Proteins (2006) 1.49
Interaction of the peptide bond with solvent water: a vapor phase analysis. Biochemistry (1978) 1.45
Fluorescence correlation spectroscopy. Methods Enzymol (2003) 1.33
Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. J Pept Res (1997) 1.30
How large is an alpha-helix? Studies of the radii of gyration of helical peptides by small-angle X-ray scattering and molecular dynamics. J Mol Biol (2005) 1.16
Huntingtin: a single bait hooks many species. Curr Opin Neurobiol (1998) 1.05
Pathological and functional amyloid formation orchestrated by the secretory pathway. Curr Opin Struct Biol (2003) 1.02
Intracellular applications of fluorescence correlation spectroscopy: prospects for neuroscience. Curr Opin Neurobiol (2003) 0.98
Cerebral amyloidoses: molecular pathways and therapeutic challenges. Curr Med Chem (2006) 0.94
Synthetic polypeptides containing side-chain amide groups. Water-soluble polymers. Biochemistry (1966) 0.81
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol (2004) 3.05
Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell (2004) 2.89
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol (2007) 2.75
Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A (2002) 2.62
Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry (2002) 2.59
Classification of intrinsically disordered regions and proteins. Chem Rev (2014) 2.48
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet (2002) 2.44
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron (2009) 2.43
Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem (2004) 2.35
Amyloid adhesins are abundant in natural biofilms. Environ Microbiol (2007) 2.35
Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci U S A (2010) 2.16
Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol (2005) 2.14
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A (2009) 2.14
NanoParticle Ontology for cancer nanotechnology research. J Biomed Inform (2010) 2.07
Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci U S A (2002) 1.89
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A (2005) 1.87
Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry (2005) 1.81
Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem (2004) 1.78
Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J Mol Biol (2010) 1.74
Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues. Proc Natl Acad Sci U S A (2013) 1.71
The kinetics of conformational fluctuations in an unfolded protein measured by fluorescence methods. Proc Natl Acad Sci U S A (2005) 1.67
Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods Enzymol (2006) 1.66
Role of backbone-solvent interactions in determining conformational equilibria of intrinsically disordered proteins. J Am Chem Soc (2008) 1.63
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60
polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci U S A (2005) 1.57
ABSINTH: a new continuum solvation model for simulations of polypeptides in aqueous solutions. J Comput Chem (2009) 1.57
Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability. J Mol Biol (2006) 1.55
Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. Biophys J (2007) 1.53
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A (2013) 1.50
Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell (2011) 1.49
Characterizing the conformational ensemble of monomeric polyglutamine. Proteins (2006) 1.49
Role of solvent in determining conformational preferences of alanine dipeptide in water. J Am Chem Soc (2004) 1.46
Structural biology. Versatility from protein disorder. Science (2012) 1.46
Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry (2005) 1.46
Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci U S A (2009) 1.45
Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol (2008) 1.43
Structural properties of Abeta protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A (2005) 1.40
Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2013) 1.39
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils. J Am Chem Soc (2011) 1.37
Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J Bacteriol (2005) 1.35
Parameters of monovalent ions in the AMBER-99 forcefield: assessment of inaccuracies and proposed improvements. J Phys Chem B (2007) 1.31
Quantitative characterization of ion pairing and cluster formation in strong 1:1 electrolytes. J Phys Chem B (2007) 1.31
Measurement of microsecond dynamic motion in the intestinal fatty acid binding protein by using fluorescence correlation spectroscopy. Proc Natl Acad Sci U S A (2002) 1.31
Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol (2009) 1.30
Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation. J Mol Biol (2006) 1.26
Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A (2007) 1.26
Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet (2006) 1.25
Reconciling observations of sequence-specific conformational propensities with the generic polymeric behavior of denatured proteins. Biochemistry (2005) 1.23
Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry (2003) 1.23
Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies. Proteins (2005) 1.22
Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci U S A (2006) 1.21
Toward an accurate theoretical framework for describing ensembles for proteins under strongly denaturing conditions. Biophys J (2006) 1.21
In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence. J Biol Chem (2007) 1.19
Catalysis of protein folding by chaperones in pathogenic bacteria. Proc Natl Acad Sci U S A (2004) 1.18
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking. Biochemistry (2004) 1.17
Molecular modeling of the core of Abeta amyloid fibrils. Proteins (2004) 1.16
Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice. J Biol Chem (2010) 1.16
Imaging polyglutamine deposits in brain tissue. Methods Enzymol (2006) 1.13
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides. Biophys Chem (2011) 1.13
Scanning cysteine mutagenesis analysis of Abeta-(1-40) amyloid fibrils. J Biol Chem (2005) 1.12
Dry molten globule intermediates and the mechanism of protein unfolding. Proteins (2010) 1.11
Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization. Biochemistry (2011) 1.09
The association−dissociation behavior of the ApoE proteins: kinetic and equilibrium studies. Biochemistry (2010) 1.09
Thermodynamics of beta-sheet formation in polyglutamine. Biophys J (2009) 1.07
Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure. Acc Chem Res (2006) 1.07
Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ. Proc Natl Acad Sci U S A (2013) 1.06
Simulations of RNA interactions with monovalent ions. Methods Enzymol (2009) 1.04
Molecular simulation studies of monovalent counterion-mediated interactions in a model RNA kissing loop. J Mol Biol (2009) 1.04
The intestinal fatty acid binding protein: the role of turns in fast and slow folding processes. Biochemistry (2002) 1.03
Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting α-helix-rich oligomeric intermediates. J Mol Biol (2011) 1.03
Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4. Biochemistry (2011) 1.02
Measuring unfolding of proteins in the presence of denaturant using fluorescence correlation spectroscopy. Biophys J (2004) 1.00
Describing sequence-ensemble relationships for intrinsically disordered proteins. Biochem J (2013) 1.00
Analysis of the conformational dependence of mass-metric tensor determinants in serial polymers with constraints. J Chem Phys (2004) 0.98
The impact of ataxin-1-like histidine insertions on polyglutamine aggregation. Protein Eng Des Sel (2009) 0.97
Assays for studying nucleated aggregation of polyglutamine proteins. Methods (2011) 0.97
β-hairpin-mediated nucleation of polyglutamine amyloid formation. J Mol Biol (2013) 0.96
Experiments and simulations show how long-range contacts can form in expanded unfolded proteins with negligible secondary structure. Proc Natl Acad Sci U S A (2013) 0.96
Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties. J Mol Biol (2012) 0.95
Observation of sequential steps in the folding of intestinal fatty acid binding protein using a slow folding mutant and 19F NMR. Proc Natl Acad Sci U S A (2007) 0.95
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J Neurosci (2006) 0.95
The E. coli CsgB nucleator of curli assembles to β-sheet oligomers that alter the CsgA fibrillization mechanism. Proc Natl Acad Sci U S A (2012) 0.94
NMR studies of 4-19F-phenylalanine-labeled intestinal fatty acid binding protein: evidence for conformational heterogeneity in the native state. Biochemistry (2005) 0.94
Real-time and equilibrium (19)F-NMR studies reveal the role of domain-domain interactions in the folding of the chaperone PapD. Proc Natl Acad Sci U S A (2002) 0.94
Methods for Monte Carlo simulations of biomacromolecules. Annu Rep Comput Chem (2009) 0.94
Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry (2012) 0.94
Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles. Biochemistry (2011) 0.94
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation. Biochemistry (2014) 0.93
Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance. Biochemistry (2014) 0.93
N-terminal segments modulate the α-helical propensities of the intrinsically disordered basic regions of bZIP proteins. J Mol Biol (2011) 0.93